Prevalence of HIV, Hepatitis B, Hepatitis C in Patients Participating in the Methadone Maintenance Treatment in Central Taiwan

中台灣美沙冬替代療法個案人類免疫缺陷病毒感染、B型肝炎感染及C型肝炎感染盛行率

許文郁(Wen-Yu Hsu)；劉瑞婷(Jui-Ting Liu)；張庭綱(Ting-Gang Chang)；廖以誠(Yi-Cheng Liao)；邱南英(Nan-Ying Chiu)

human immunodefi ciency virus (HIV) ； hepatitis B virus (HBV) ； hepatitis C virus (HCV) ； methadone maintence treatment (MMT)

台灣精神醫學

27卷1期（2013 / 03 / 01）

33 - 40

英文

Objective: Transmission of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) are important issues in heroin addicts. In this study, we investigated the prevalences of HIV, HBV, and HCV infections and analyzed the associations between relative factors in heroin addicts, who were enrolled in the methadone maintenance treatment (MMT), in central Taiwan from January 2007 to February 2011. Method: This is a retrospect study. We reviewed the medical records of subjects enrolling in the MMT in Changhua Christian Hospital, a medical center, and Lu tung Branch of Changhua Christian Hospital, a psychiatric subspecialty hospital, in central Taiwan. Results: We enrolled 1,149 subjects, including 1,012 male subjects (88.1%) and 137 female subjects (11.9%). We found that 232 subjects (20.2%) had HIV, 546 subjects (47.5%) HBsAb-positive, and 335 subjects (29.2%) hepatitis B-positive status. A total of 982 subjects (85.5%) was found to have hepatitis C infection, including 757 non-HIV subjects (82.6%) and 225 HIV carriers (97.0%). We found that there was significant relationship between intravenous injection and HCV-positive status (p ＜ 0.001). Subjects with HCV-positive status had significantly higher GOT (p ＜ 0.05), higher GPT (p ＜ 0.001), younger age of heroin first time using (p ＜ 0.001), more abstinence heroin times (p ＜ 0.001), and longer heroin using duration (p ＜ 0.001). Male (p ＜ 0.05), intravenous injection user (p ＜ 0.001), lower education level (p ＜ 0.05), unemployment status (p ＜ 0.05), and HCV infection were related with HIV-positive status. Subjects with HIV positive status also had significant higher mean of γ-GT (p ＜ 0.05), older age (p ＜ 0.05), times of heroin abstinence (p ＜ 0.05), and heroin using duration (p ＜ 0.001). Conclusion: This population should be closely followed for their infection condition, and receive effective intervention more early. Further basic or clinical studies for co-infection of HCV and HIV are needed.

1. Agdamag, D.,Kageyama, S.,Alesna, E. T.(2005).Rapid spread of hepatitis C virus among injecting-drug users in the Philippines: Implications for HIV epidemics.J Med Virol,77,221-6.
2. Backmund, M.,Reimer, J.,Meyer, K.,Gerlach, J. T.,Zachoval, R.(2005).Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment.Clin Infect Dis,40(Suppl 5),S330-5.
3. Bani-Sadr, F.,Lapidus, N.,Rosenthal, E.(2009).Gamma glutamyl transferase elevation in HIV/Hepatitis C virus-coinfected patients during interferon-ribavirin combination therapy.J Acquir Immune Defic Syndr,50,429-30.
4. Bani-Sadr, F.,Miailhes, P.,Rosenthal, E.(2008).Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patients.AIDS,22,1234-6.
5. Bradshaw, C. S.,Pierce, L. I.,Tabrizi, S. N.,Fairley, C. K.,Garland, S. M.(2005).Screening injecting drug users for sexually transmitted infections and blood borne viruses using street outreach and self collected sampling.Sex Transm Infect,81,53-8.
6. Broers, B.,Junet, C.,Bourquin, M.,Deglon, J. J.,Perrin, L.,Hirschel, B.(1998).Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995.AIDS,12,2059-66.
7. Chen, C. H.,Yang, P. M.,Huang, G. T.,Lee, H. S.,Sung, J. L.,Sheu, J. C.(2007).Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a largescale survey of free hepatitis screening participants.J Formos Med Assoc,106,148-55.
8. Chen, K. T.,Chang, H. L.,Chen, C. T.,Chen, Y. A.(2009).The changing face of the HIV epidemic in Taiwan: a new challenge for public health policy strategies.AIDS Patient Care STDS,23,195-201.
9. Chu, F. Y.,Chiang, S. C.,Su, F. H.,Chang, Y. Y.,Cheng, S. H.(2009).Prevalence of human immunodefi ciency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan.J Med Virol,81,973-8.
10. Hallinan, R.,Byrne, A.,Amin, J.,Dore, G. J.(2005).Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.J Gastroenterol Hepatol,20,1082-6.
11. Johnston, L.,Saumtally, A.,Corceal, S.,Mahadoo, I.,Oodally, F.(2011).High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: Findings from a population size estimation and respondent driven sampling survey.Int J Drug Policy,22,252-8.
12. Kral, A. H.,Bluthenthal, R. N.,Lorvick, J.,Gee, L.,Bacchetti, P.,Edlin, B. R.(2001).Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis.Lancet,357,1397-401.
13. Lee, K. C.,Lim, W. W.,Lee, S. S.(2008).High prevalence of HCV in a cohort of injectors on methadone substitution treatment.J Clin Virol,41,297-300.
14. Lee, T. S.,Shen, H. C.,Wu, W. H.(2011).Clinical characteristics and risk behavior as a function of HIV status among heroin users enrolled in methadone treatment in northern Taiwan.Subst Abuse Treat Prev Policy,6,6.
15. Mahanta, J.,Borkakoty, B.,Das, H. K.,Chelleng, P. K.(2009).The risk of HIV and HCV infections among injection drug users in northeast India.AIDS Care,21,1420-4.
16. Miller, E. R.,Hellard, M. E.,Bowden, S.,Bharadwaj, M.,Aitken, C. K.(2009).Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.J Infect,58,375-82.
17. Myers, R. P.,Benhamou, Y.,Imbert-Bismut, F.(2003).Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients.AIDS,17,721-5.
18. Nelson, K. E.,Galai, N.,Safaeian, M.,Strathdee, S. A.,Celentano, D. D.,Vlahov, D.(2002).Temporal trends in the incidence of human immunodefi ciency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998.Am J Epidemiol,156,641-53.
19. Ni, Y. H.,Chen, D. S.(2010).Hepatitis B vaccination in children: the Taiwan experience.Pathol Biol,58,296-300.
20. Quaglio, G.,Lugoboni, F.,Pattaro, C.(2006).Patients in long-term maintenance therapy for drug use in Italy: analysis of some parameters of social integration and serological status for infectious diseases in a cohort of 1091 patients.BMC Public Health,6,216.
21. Rosengard, C.,Anderson, B.,Stein, M. D.(2004).Intravenous drug users' HIV-risk behaviors with primary/other partners.Am J Drug Alcohol Abuse,30,225-36.
22. Shapatava, E.,Nelson, K. E.,Tsertsvadze, T.,del Rio, C.(2006).Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.Drug Alcohol Depend,82(Suppl 1),S35-8.
23. Sievert, W.,Altraif, I.,Razavi, H. A.(2011).A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt.Liver Int,31(Suppl 2),61-80.
24. Toskulkao, T.,Pornchai, R.,Akkarapatumwong, V.,Vatanatunyakum, S.,Govitrapong, P.(2010).Alteration of lymphocyte opioid receptors in methadone maintenance subjects.Neurochem Int,56,285-90.
25. Touzet, S.,Kraemer, L.,Colin, C.(2000).Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature. HENCORE Group (Hepatitis C European Network for Co-operative Research).Eur J Gastroenterol Hepatol,12,667-78.
26. Wang, X.,Zhang, T.,Ho, W. Z.(2011).Opioids and HIV/HCV Infection.J Neuroimmune Pharmacol,6,477-89.

1. Lin, Shih-Ku(2013).Health Problems in Patients Receiving Methadone Maintenance Treatment: A Call for Therapy Action.台灣精神醫學,27(1),5-6.
2. 楊延光,陸汝斌,陳柏熹,張惠華,柯韋名,周辰熹,李嵐婷,王姿云(2015).Correlation between Cytochrome P450 2D6 Genotype and Methadone Concentration-to-dose Ratio.臺灣精神醫學,29(3),180-190+iii.